Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. NAFLD progresses from benign steatosis to steatohepatitis (NASH) to cirrhosis and is linked to hepatocellular carcinoma. No targeted treatment is currently approved for NAFLD/NASH. We previously showed that fat-s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Lipid Res
Autors principals: Rajamoorthi, Ananthi, Arias, Noemí, Basta, Jeannine, Lee, Richard G., Baldán, Ángel
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Biochemistry and Molecular Biology 2017
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5665668/
https://ncbi.nlm.nih.gov/pubmed/28874443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M077941
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars